<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study examined the protective effects of cilostazol on cerebral <z:mpath ids='MPATH_124'>infarcts</z:mpath> produced by subjecting rats to 2-h occlusion of the left middle cerebral artery followed by 24-h reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>The ischemic cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> consistently involved the cortex and striatum </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> size was significantly reduced, when rats received 10 mg/kg cilostazol intravenously 5 min or 1 h after the completion of 2-h <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Cyclic <z:chebi fb="47" ids="16027,28971">AMP</z:chebi> level was significantly elevated in the cortex of 4- and 12-h reperfusion (P &lt; 0.01) following treatment with cilostazol (10 mg/kg, 5 min after 2-h <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) accompanied by decreased <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha level </plain></SENT>
<SENT sid="4" pm="."><plain>Samples from the regions corresponding to the penumbra showed markedly reduced Bcl-2 protein level and, in contrast, high levels of Bax protein and <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> release </plain></SENT>
<SENT sid="5" pm="."><plain>Cilostazol decreased Bax protein and <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> release and increased the levels of Bcl-2 protein </plain></SENT>
<SENT sid="6" pm="."><plain>Cilostazol (10(-7)-10(-5) M) potently and concentration dependently scavenged <z:chebi fb="10" ids="29191">hydroxyl</z:chebi> and <z:chebi fb="0" ids="25935">peroxyl radicals</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, cilostazol treatment decreases ischemic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> in association with inhibition of apoptotic and oxidative cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>